Stay updated on TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.

Latest updates to the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedAdditions were recorded on 2026-03-09, 2026-03-05, and 2026-03, and deletions were recorded on 2025-08-07, 2025-08-04, and 2025-08.SummaryDifference0.2%

- Check10 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page. No user-facing content or functionality is altered.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedA minor version update was applied, from v3.4.1 to v3.4.2, with no changes to the displayed study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

- Check83 days agoChange DetectedAdded a consolidated Locations section listing study sites across multiple regions (California, Florida, Illinois, Massachusetts, Missouri, British Columbia, Ontario, Quebec, Lombardy, Madrid). Removed the previous separate location subsections.SummaryDifference1.0%

Stay in the know with updates to TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TACTIVE-U Study of ARV-471 Combo in Adv Breast Cancer Clinical Trial page.